Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 8;12(5):1337.
doi: 10.3390/nu12051337.

Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies

Affiliations

Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies

Salvatore Benvenga et al. Nutrients. .

Abstract

Nutraceuticals are defined as a food, or parts of a food, that provide medical or health benefits, including the prevention of different pathological conditions, and thyroid diseases, or the treatment of them. Nutraceuticals have a place in complementary medicines, being positioned in an area among food, food supplements, and pharmaceuticals. The market of certain nutraceuticals such as thyroid supplements has been growing in the last years. In addition, iodine is a fundamental micronutrient for thyroid function, but also other dietary components can have a key role in clinical thyroidology. Here, we have summarized the in vitro, and in vivo animal studies present in literature, focusing on the commonest nutraceuticals generally encountered in the clinical practice (such as carnitine, flavonoids, melatonin, omega-3, resveratrol, selenium, vitamins, zinc, and inositol), highlighting conflicting results. These experimental studies are expected to improve clinicians' knowledge about the main supplements being used, in order to clarify the potential risks or side effects and support patients in their use.

Keywords: carnitine; flavonoids; melatonin; nutraceuticals; omega-3; resveratrol; selenium; thyroid; vitamins; zinc.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Summary of the main findings. NIS, sodium/iodide symporter; TPO, thyroid peroxidase; AIT, autoimmune thyroiditis.

References

    1. Benvenga S., Feldt-Rasmussen U., Bonofiglio D., Asamoah E. Nutraceutical Supplements in the Thyroid Setting: Health Benefits beyond Basic Nutrition. Nutrients. 2019;11:2214. doi: 10.3390/nu11092214. - DOI - PMC - PubMed
    1. Lockwood G.B. The quality of commercially available nutraceutical supplements and food sources. J. Pharm. Pharmacol. 2011;63:3–10. doi: 10.1111/j.2042-7158.2010.01159.x. - DOI - PubMed
    1. European Parliament Regulation EU 2015/2283 of the European Parliament and of the Council of 25 November 2015 on Novel Foods, Amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and Repealing Regulation (EC) No 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No 1852/2001. [(accessed on 13 March 2020)]; Available online: https://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX%3A32015R2283.
    1. Galetta F., Franzoni F., Bernini G., Poupak F., Carpi A., Cini G., Tocchini L., Antonelli A., Santoro G. Cardiovascular complications in patients with pheochromocytoma: A mini-review. Biomed. Pharmacother. 2010;64:505–509. doi: 10.1016/j.biopha.2009.09.014. - DOI - PubMed
    1. Galetta F., Franzoni F., Fallahi P., Tocchini L., Braccini L., Santoro G., Antonelli A. Changes in heart rate variability and QT dispersion in patients with overt hypothyroidism. Eur. J. Endocrinol. 2008;158:85–90. doi: 10.1530/EJE-07-0357. - DOI - PubMed

Publication types